Low-THC CBD-Rich Cannabis Produced Detectable Blood THC Despite Null Task Comparisons
CBD-rich cannabis containing less than 1% THC still produced measurable whole-blood THC in a randomized trial. The study did not find significant differences on its overall computerized driving-related assessment, illustrating why exposure and functional endpoints must be reported separately.
Product percentage was not the administered amount
Participants vaporized two CBD-rich products or placebo. One product supplied approximately 38 mg CBD and 1.8 mg THC; the other supplied approximately 39 mg CBD and 0.6 mg THC.
Twenty-seven participants completed the single-use study arm and 20 completed the repetitive-use arm. These completer counts should not be replaced by the larger number initially included. The product with a higher THC amount also produced different concentration and detection patterns.
A positive concentration did not define the task result
Whole-blood THC was detectable after exposure, sometimes for hours. Overall pairwise comparisons of driving-related ability did not significantly distinguish the active products from placebo.
The functional assessment was computerized testing rather than a comprehensive on-road evaluation. Individual performance categories also varied within conditions, including placebo. A null group comparison is not a guarantee that every participant performed normally.
How to apply the distinction
The findings refute the assumption that a low THC percentage means no THC exposure. They do not establish that any detectable concentration necessarily demonstrates impairment, nor that CBD universally cancels the effects of THC.
Product mass, actual cannabinoid dose, use frequency and sampling time all belong in an interpretation. The tested low-THC products and selected healthy volunteers cannot establish outcomes for higher-THC cannabis, concurrent alcohol or an individual incident. The study’s analytical and functional findings remain useful precisely when those boundaries are retained.
Related: Why concentrations do not establish functional impairment.
Primary research
Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability – a randomized clinical trial. International Journal of Legal Medicine (2023).
